Thu, Nov 27, 2014, 3:57 AM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • spice.kake spice.kake Feb 5, 2013 10:30 PM Flag

    Observation on Exel's board.

    We have shorts playing their games, meanwhile markets are poised for a 1700 S&P. Exel have been a lagger for more than 2 years. Why? Short Interest had control for the last years, but things are changing in a hurry. As markets shows signs of Global recovery, we may bounce off these levels into a much dseirable position as Exel's pipeline approaches 2014 and other milestones with Big Pharma's. We could be entering a progressive phase of Large Pharma's pocket books before 2014 Completion of Exels most dramatic portofolio. CABO, Comet trials. Get ready for recognition from Large Pharma's. We are in a different phase with Exel. Its just going to be good and get better . Look for Bidders. $'S For Large Pharma's are mow, while Exels are still cheap. Pharma's would rather get a complete pipeline with accessories at $15.00 rather than $50- $100.

    Sentiment: Buy

 
EXEL
1.76+0.040(+2.33%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.